Bhat A, Bhat M, Prasad K, Trivedi D, Acharya S. Estimation of Pyruvic acid in serum and saliva among healthy and potentially malignant disorder subjects – a stepping stone for cancer screening?. J Clin Exp Dent. 2015;7(4):e462-5.





1. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-23.


2. Sankaranarayanan R, Mathew B, Jacob B, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. Cancer. 2000;88:664-73<664::AID-CNCR25>3.0.CO;2-V



3. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ. 2005;69:255-65.


4. McLeod NM, Saeed NR, Ali EA. Oral cancer: delays in referral and diagnosis persist. Br Dent J. 2005;198:681-84.


5. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927-30.


6. Scatena R, Bottoni P, Pontoglio A, Giardina B. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy. Proteomics Clin Appl. 2010;4:143-58.


7. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drugresistance associated withmitochondrial respiratory defect and hipoxia. Cancer Res. 2005;65:613-21.


8. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459-65.



9. Hammerman PS, Fox CJ, Thompson CB. Beginnings of a signaltransduction pathway for bioenergetics control of cell survival. Trends Biochem Sci. 2004;29:586-92.


10. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393-418.


11. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res.2006;66:8927-30.



12. Garber K. Energy deregulation: licensing tumor to grow. Science. 2006;312:1158–9.


13. Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ. Imatinib (STI571) – mediated changes in glucose metabolism in human leukaemia BCR-ABL-positive cells. Clin Cancer Res. 2004;10:6661-8.


14. Costello LC, Franklin RB. Why do tumour cells glycolyse from glycolysis?:through citrate to lipogenesis. Mol. Cell Biochem. 2005;280:1-8.



15. Shaw RJ. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 2006;18:598-608.


16. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008;13:472-82.


17. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008;18:54-61.
PMid:18387799 PMCid:PMC2476215


18. Henze K, Martin W. Evolutionary biology: essence of Mitocondria. Nature. 2003;426:127-8.